Susquehanna International Group
HUMA icon

Susquehanna International Group’s Humacyte HUMA Stock Holding History

Susquehanna International Group’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$253K Buy
414,000
+71,700
+21% +$74.5K ﹤0.01% 11250
2025
Q4 		$329K Buy
342,300
+261,000
+321% +$370K ﹤0.01% 9741
2025
Q3 		$141K Sell
81,300
-103,300
-56% -$202K ﹤0.01% 11324
2025
Q2 		$386K Sell
184,600
-109,800
-37% -$211K ﹤0.01% 9782
2025
Q1 		$503K Sell
294,400
-66,400
-18% -$249K ﹤0.01% 8892
2024
Q4 		$1.82M Buy
360,800
+296,400
+460% +$1.47M ﹤0.01% 5531
2024
Q3 		$350K Sell
64,400
-208,500
-76% -$1.37M ﹤0.01% 9267
2024
Q2 		$1.31M Buy
+272,900
New +$1.42M ﹤0.01% 5959
2022
Q4 		– Sell
-49,400
Closed -$161K – 12950
2022
Q3 		$161K Buy
49,400
+28,900
+141% +$111K ﹤0.01% 11139
2022
Q2 		$66K Sell
20,500
-30,900
-60% -$172K ﹤0.01% 11806
2022
Q1 		$363K Sell
51,400
-153,300
-75% -$893K ﹤0.01% 9784
2021
Q4 		$1.48M Sell
204,700
-139,600
-41% -$1.38M ﹤0.01% 6243
2021
Q3 		$4M Buy
+344,300
New +$3.94M ﹤0.01% 4361

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Susquehanna International Group's HUMA Position: Q1 2026 in Review

Susquehanna International Group increased its Humacyte (HUMA) stake by 4.8% in Q1 2026, buying an estimated $50.3K and bringing the position to 1,058,048 shares worth $642K. The position accounts for ﹤0.01% of the portfolio, ranked #9022.

Susquehanna International Group first reported a position in HUMA in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.95M in Q4 2024. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • Susquehanna International Group held 1,058,048 shares of Humacyte worth $642K as of Q1 2026.
  • Susquehanna International Group bought 48,378 Humacyte shares in Q1 2026, an estimated $50.3K.
  • Humacyte made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9022 holding.
  • Susquehanna International Group first reported a position in Humacyte in Q1 2022 and has held it in 17 quarters since.
  • Susquehanna International Group's Humacyte position peaked at $3.95M in Q4 2024.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.